Cohance
Live Price
Recent news and updates for COHANCE will appear here soon.
"Balanced market signals for COHANCE. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally. The company offers small molecule APIs, advanced intermediates, and starting materials; antibody drug conjugates; high-purity oligonucleotide building blocks comprising phosphoramidites, nucleosides, pseudouridine, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes; pellets and finished dosage forms; and specialty chemicals, including agrochemicals. It serves pharmaceutical, biotechnology, and chemical companies. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is headquartered in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.
As of the latest market session, Cohance (COHANCE) is trading at ₹428, representing a move of 2.61% from the previous close.
Cohance is listed and traded under the ticker symbol COHANCE on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Cohance's stock price moved by 2.61%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 50% bullish probability for COHANCE stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Cohance shares reached a high of ₹1,038.9 and hit a low of ₹266.7.
COHANCE exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 5,05,391 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Cohance has a market capitalization of ₹16375.17 Cr, designating its size class inside the Healthcare sector.
Cohance has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Cohance's trailing Price-to-Earnings (P/E) ratio is 91.65. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Cohance (COHANCE) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Cohance's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore COHANCE's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for COHANCE are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Cohance operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.